47.73.Z - Retail sale of pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
47.19.Z - Retail trade
47.29.Z - Retail trade
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
47.91.Z - Intermediary retail sale, non-specialized
52.10.B - Warehousing and storage of other goods
64.99.Z - Other financial services, except insurance and pension funds, not elsewhere classified
86.90.E - Healthcare
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | 1,5 | 2 | 1,6 | -21,2 |
Gross profit (loss) | 1,6 | 2,8 | 1,5 | -44,7 |
EBITDA | 1,4 | 1,9 | 1,6 | -17,2 |
Short time liabilities | 8,3 | 6,6 | 6 | -9,6 |
Other operating costs | 0,1 | 0,1 | 0,1 | -8 |
Equity capital | -4,9 | -2,6 | -1,3 | 50,6 |
Operating profit (EBIT) | 1,3 | 1,9 | 1,5 | -21,7 |
Assets | 3,5 | 4,3 | 4,9 | 14,7 |
Net profit (loss) | 1,3 | 2,3 | 1,3 | -44,5 |
Cash | 0 | 0 | 0,1 | 68,6 |
Net income from sale | 17,6 | 21,2 | 23,4 | 10 |
Liabilities and provisions for liabilities | 8,4 | 6,9 | 6,2 | -9,6 |
Working assets | 2,6 | 2,9 | 3,7 | 24,4 |
Other income costs | 0 | 0 | 0 | 7,7 |
Depreciation | 0 | 0 | 0,1 | 189,7 |
% | % | % | p.p. | |
Profitability of capital | -26,8 | -91,2 | -102,5 | -11,3 |
Equity capital to total assets | -138,1 | -59,3 | -25,5 | 33,8 |
Gross profit margin | 9,3 | 13,1 | 6,6 | -6,5 |
EBITDA Margin | 7,8 | 9,1 | 6,8 | -2,3 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 172 | 114 | 94 | -20 |
Current financial liquidity indicator | 0.31329548358917236 | 0.44324955344200134 | 0.6100464463233948 | 0,2 |
Net dept to EBITDA | -0.01506796944886446 | -0.01703198067843914 | -0.03467247262597084 | 0 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane